BNT211: A phase I/II trial to evaluate safety and efficacy of CLDN6 CAR-T cells and CARVac-mediated in vivo expansion in patients with CLDN6+advanced solid tumors - Haanen, J.; Mackensen, Andreas; Koenecke, C.; Alsdorf, W.; Desuki, A.; Wagner-Drouet, E.; Heudobler, D.; Borchmann, P.; Wiegert, E.; Schulz, C.; Rengstl, B.; Preussner, L.; et al. (ANNALS OF ONCOLOGY, 2021)
CRIS-Team WoS Importer:2021-12-31